Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues

Journal of Clinical Pathology

Volumn 51, Issue 9, 1998, Pages 657-661

  Walmsley, R S ^a,b   Anthony, A ^a   Sim, R ^a   Pounder, R E ^a   Wakefield, A J ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b SOUTHEND HOSPITAL   (United Kingdom)

Author keywords

Crohn's disease; Escherichia coli; Klebsiella pneumoniae; Listeria monocytogenes

Indexed keywords

ANTIGEN RECOGNITION; ARTICLE; BACTERIUM DETECTION; CROHN DISEASE; ESCHERICHIA COLI; HUMAN; HUMAN TISSUE; KLEBSIELLA PNEUMONIAE; LISTERIA MONOCYTOGENES; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0031716014     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.51.9.657     Document Type: Article

References (26)

1. Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991;338:771-4.
2. Rutgeerts P, Heile M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995;108:1617-21.
3. Gardiner KR, Halliday MI, Barclay GR, et al. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 1995;36:897-901.
4. Sadlack B, Merz H, Schorle H, et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-61.
5. Kuhn R, Lohler J, Rennick D, et al. Interleukin-10 deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
6. Wensinck F, van de Merwe JP. Serum agglutinins to eubacterium and peptostreptococcus species in Crohn's and other diseases. J Hygiene 1981;87:13-24.
7. Auer IO, Rhoder A, Wensinck F, et al. Selected bacterial antibodies in Crohn's disease and ulcerative colitis. Scand J Gastroenterol 1983;18:217-23.
8. Ibbotson JP, Pease PE, Allan RE. Serological studies in Crohn's disease. Eur J Clin Microbiol 1987;6:286-90.
9. Cooper R, Fraser SM, Sturrock RD, et al. Raised titres of anti-klebsiella IgA in ankylosing spondylitis, rheumatoid arthritis and inflammatory bowel disease. BMJ 1988;296: 1432-4.
10. Tiwana H, Wilson C, Walmsley RS, et al. Antibody responses to gut bacteria in ankylosing spondylitis , rheumatoid arthritis, Crohn's disease and ulcerative colitis. Rheumatol Int 1997;17:11-16.
11. Klasen IS, Melief MJ, van Halerteren AGS, et al. The presence of peptidoglycan-polysaccharide complexes in the bowel wall and the cellular responses to these complexes in Crohn's disease. Clin Immunol Immunopathol 1994;17:310-18.
12. Liu Y, Van Kruningen J, West AB, et al. Immunocytochemical evidence of listeria, Escherichia coli and streptococcus antigens in Crohn's disease. Gastroenterology 1995;108: 1396-404.
13. Ollett WS. A method for staining both Gram positive and Gram negative bacteria in sections. J Pathol Bacteriol 1947; 59:357.
14. Satsanghi J, Welsh KI, Bunce M, et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996;347:1212-17.
15. Gent A, Hellier MD, Grace RH, et al. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994;343: 766-7.
16. Lagercrantz R, Hammarstrom S, Perlmann P, et al. Immunological studies in ulcerative colitis IV: origin of autoantibodies. J Exp Med 1968;128:1339-52.
17. Dickinson RJ, Varian SA, Axon AT, et al. Increased incidence of faecal isoforms with in vitro adhesive and invasive properties in patients with ulcerative colitis. Gut 1980;21:787-92.
18. Burke DA, Axon AT. Ulcerative colitis and Escherichia coli with adhesive properties. J Clin Pathol 1987;40:782-6.
19. O'Mahony S, Anderson N, Nuki G, et al. Systemic and mucosal antibodies to klebsiella in patients with ankylosing spondylitis and Crohn's disease. Ann Rheum Dis 1992;51: 1296-300.
20. Mielants H, Veys EM, Cuvelier C, et al. Ileocolonoscopic findings in seronegative spondylarthropathies. Br J Rheumatol 1988;27(suppl II):95-105.
21. de Vos M, Mielants H, Cuvelier C, et al. Long-term evolution of gut inflammation in patients with spondyloarthropathy. Gastroenterology 1996;110:1696-703.
22. Leirisalo-Repo M, Turunen U, Stenman S, et al. High frequency of silent inflammatory bowel disease in spondyloarthropathy. Arthritis Rheum 1994;37:23-31.
23. Muller HE. Listeria isolations from faeces of patients with diarrhoea and from healthy food handlers. Infection 1990;18:97-100.
24. Khilkin M, Swidinski A, Schreiber S, et al. Bacterial invasion of the mucosa is an essential component of inflammation in inflammatory bowel disease [abstr]. Gastroenterology 1997; 112:A1012.
25. Rhodes JM. Mucins in inflammatory bowel disease. Q J Med 1997;90:79-82
26. Duchmann R, Kaiser I, Hermann E, et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease. Clin Exp Immunol 1995;102: 448-55.